new vaccines

GSK, CureVac to Make COVID-19 Vaccines Aimed at New Variants

The logo of the biotech company Curevac with the slogan “the RNA people” (Sebastian Gollnow/dpa via AP) LONDON (AP) – U.K.-based drugmaker GlaxoSmithKline and Germany’s CureVac say they plan to collaborate to develop new vaccines that can target emerging variants of COVID-19. The announcement comes as public health experts around the world raise concerns about mutations in the virus that…